ResearcherUniversity Medical Center Hamburg-EppendorfNo recent work listed

Johannes Taeger

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-9018-6915; OpenAlex author ID A5021552080. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2011: 1 paper

Papers 1

Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial cells, and pericytes in pancreatic cancer. Co-author DOI 10.1158/1535-7163.mct-11-0312 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Oliver Stoeltzing · 1 shared paper, 2011 · strength 0.03
- Paper Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial ce… DOI 10.1158/1535-7163.mct-11-0312 ↗
Sven Arke Lang · 1 shared paper, 2011 · strength 0.03
- Paper Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial ce… DOI 10.1158/1535-7163.mct-11-0312 ↗
Christian Moser · 1 shared paper, 2011 · strength 0.03
- Paper Targeting FGFR/PDGFR/VEGFR impairs tumor growth, angiogenesis, and metastasis by effects on tumor cells, endothelial ce… DOI 10.1158/1535-7163.mct-11-0312 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.